People with Parkinson’s and healthcare professionals can view clinical trials taking place across Europe using a new map on the Clinical Trials Information System (CTIS)’s public website.
The map is intended to increase access to clinical research in the EU. It offers patients and healthcare professionals easy access to real-time information about trials being conducted in their area.
The new launch is part of the Accelerating Clinical Trials in the European Union (ACT EU) workplan for 2025-2026. It comes in response to stakeholders’ request for a patient-friendly dashboard to help locate clinical trials in Europe.
Users can filter the map’s results by medical condition – such as Parkinson’s – as well as country, and whether the trial is recruiting. Each featured trial includes a clickable link to more information.
Parkinson’s clinicial trials
“The map currently displays information on over 50 clinical trials on Parkinson’s disease, around 20 of which are recruiting participants,” said a spokesperson for the European Medicines Agency, which launched the website.
“Search results offer investigators’ contact details, enabling members of the public to directly enquire about potential enrolment in a given trial. By ensuring public access to accurate information, the clinical trial map facilitates recruitment and accelerates the conduct of clinical trials in Europe.”
Parkinson’s Europe Strategic Director Amelia Hursey added: “The best thing about this map is that we can easily see where in the European Union research trials are happening. It means anyone can have a look at it and search for their area of interest and then click on the map pin to find out who to contact about the research.
“It’s a fantastic tool, allowing people with Parkinson’s to see how much research is happening.”
Find out more about Parkinson’s research here.
